Fidelman, Nicholas
Atreya, Chloe E.
Griffith, Madeline
Milloy, M. Alexandra
Carnevale, Julia
Cinar, Pelin
Venook, Alan P.
Van Loon, Katherine
Article History
Received: 1 September 2022
Accepted: 5 December 2022
First Online: 13 December 2022
Declarations
:
: The protocol was reviewed and approved by the Institutional Review Board (IRB) at University of California San Francisco (CC#16452). The study was performed in accordance with the Declaration of Helsinki. All patient signed written informed consent after being advised of risks, benefits, and alternatives of study treatments and trial participation.
: Not applicable.
: This study was supported by an independent research grant from SIRTEX Medical, Inc. to University of California San Francisco (Nicholas Fidelman, Principal Investigator). None of the other authors have any relevant conflict of interest disclosures.